These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10371576)

  • 1. Plasma homocysteine and all-cause mortality in diabetes.
    Kark JD; Selhub J; Bostom A; Adler B; Rosenberg IH
    Lancet; 1999 Jun; 353(9168):1936-7. PubMed ID: 10371576
    [No Abstract]   [Full Text] [Related]  

  • 2. Dietary diversity no longer offsets the mortality risk of hyperhomocysteinaemia in older adults with diabetes: a prospective cohort study.
    Wahlqvist ML; Xiu L; Lee MS; Chen RC; Chen KJ; Li D
    Asia Pac J Clin Nutr; 2016; 25(2):414-23. PubMed ID: 27222426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum folate levels and fatality among diabetic adults: A 15-y follow-up study of a national cohort.
    Afriyie-Gyawu E; Ifebi E; Ampofo-Yeboah A; Kyte B; Shrestha S; Zhang J
    Nutrition; 2016 Apr; 32(4):468-73. PubMed ID: 26746677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease.
    Ndrepepa G; Kastrati A; Braun S; Koch W; Kölling K; Mehilli J; Schömig A
    Clin Chim Acta; 2006 Nov; 373(1-2):70-6. PubMed ID: 16814762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated baseline plasma phospholipid protein (PLTP) levels are an independent predictor of long-term all-cause mortality in patients with diabetes mellitus and known or suspected coronary artery disease.
    Cavusoglu E; Marmur JD; Chhabra S; Hojjati MR; Yanamadala S; Chopra V; Eng C; Jiang XC
    Atherosclerosis; 2015 Apr; 239(2):503-8. PubMed ID: 25710294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum homocysteine is a predictor of accelerated decline in renal function and chronic kidney disease: A historical prospective study.
    Levi A; Cohen E; Levi M; Goldberg E; Garty M; Krause I
    Eur J Intern Med; 2014 Dec; 25(10):951-5. PubMed ID: 25457436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria.
    Stehouwer CD; Gall MA; Hougaard P; Jakobs C; Parving HH
    Kidney Int; 1999 Jan; 55(1):308-14. PubMed ID: 9893141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic complication of diabetes and homocysteine].
    Idzior-Waluś B; Cieślik G
    Przegl Lek; 2000; 57(12):732-5. PubMed ID: 11398598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine and vitamin B(12) concentrations and mortality rates in type 2 diabetes.
    Looker HC; Fagot-Campagna A; Gunter EW; Pfeiffer CM; Sievers ML; Bennett PH; Nelson RG; Hanson RL; Knowler WC
    Diabetes Metab Res Rev; 2007 Mar; 23(3):193-201. PubMed ID: 16845688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prognostic significance of homocysteine in middle-aged and elderly.
    Petersen JF; Larsen BS; Sabbah M; Nielsen OW; Kumarathurai P; Sajadieh A
    Biomarkers; 2016 Sep; 21(6):490-6. PubMed ID: 27008914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of plasma homocysteine in hypertensive patients with diabetes mellitus.
    Qureshi M; Khsandwala H; Haq IU; Prasad K
    J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):261-6. PubMed ID: 14740075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine level and other biochemical parameters in cardiovascular disease patients with diabetes mellitus.
    Ajabnoor MA; AL-Ama MN; Banjar Z; Rafee AA; Sheweita SA
    Med Sci Monit; 2003 Dec; 9(12):CR523-7. PubMed ID: 14646975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality.
    Shaw JE; Hodge AM; de Courten M; Chitson P; Zimmet PZ
    Diabetologia; 1999 Sep; 42(9):1050-4. PubMed ID: 10447514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrelationship between diabetes and homocysteine metabolism: hormonal regulation of cystathionine beta-synthase.
    Schalinske KL
    Nutr Rev; 2003 Apr; 61(4):136-8. PubMed ID: 12795447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.
    Suliman M; Stenvinkel P; Qureshi AR; Kalantar-Zadeh K; Bárány P; Heimbürger O; Vonesh EF; Lindholm B
    Nephrol Dial Transplant; 2007 Jan; 22(1):209-17. PubMed ID: 16982634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical relevance of homocysteine monitoring in the diabetic patient].
    Benmerabet S; Fredenrich A; Robillon JF; Canivet B; Candito M; Van Obberghen E
    Diabetes Metab; 2002 Dec; 28(6 Pt 1):510-5. PubMed ID: 12522334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes.
    Mueller T; Hinterreiter F; Luft C; Poelz W; Haltmayer M; Dieplinger B
    J Vasc Surg; 2014 May; 59(5):1291-9. PubMed ID: 24393280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonfasting plasma total homocysteine level and mortality.
    Eisner MD
    Ann Intern Med; 2000 May; 132(9):759-60. PubMed ID: 10787375
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevated homocysteine as a risk factor for the development of diabetes in women with a previous history of gestational diabetes mellitus: a 4-year prospective study.
    Cho NH; Lim S; Jang HC; Park HK; Metzger BE
    Diabetes Care; 2005 Nov; 28(11):2750-5. PubMed ID: 16249551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma homocysteine levels and mortality in patients with coronary artery disease.
    Nygård O; Nordrehaug JE; Refsum H; Ueland PM; Farstad M; Vollset SE
    N Engl J Med; 1997 Jul; 337(4):230-6. PubMed ID: 9227928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.